InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+7.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Watkins Tim, Directeur Marketing. Insider active across 1 company, notably Contineum Therapeutics, Inc.. In total, 6 disclosures have been logged. Breakdown: 0 buy · 1 sell. Activity tracked since 29 December 2025. The latest transaction was disclosed on 28 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
10,833 sharesClass A Common StockSEC:0001628280-26-046654:0
10,833 sharesClass A Common StockSEC:0001628280-26-046654:1
3,611 shares@ US$4.5024.7% of flowClass A Common StockSEC:0001437749-26-002575
3,611 shares@ US$4.500.0032% mcap24.7% of flowClass A Common StockSEC:0001437749-26-002575:0
3,611 shares@ US$4.5025.3% of flowClass A Common StockSEC:0001437749-25-038938
3,611 shares@ US$4.500.0032% mcap25.3% of flowClass A Common StockSEC:0001437749-25-038938:0
6 of 6 declarations
About Watkins Tim
Watkins Tim serves as Chief Marketing Officer and Head of Development at Contineum Therapeutics, Inc. In this role, he oversees the company's marketing and business development strategies. His expertise in marketing enables him to lead initiatives aimed at increasing brand visibility and developing new markets. Tim plays a key role in formulating growth strategies.
